- Report
- September 2023
- 162 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Report
- October 2023
- 207 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Report
- July 2019
- 151 Pages
Global
From €1321EUR$1,375USD£1,130GBP
€2642EUR$2,750USD£2,259GBP
- Report
- September 2020
- 163 Pages
Global
From €1321EUR$1,375USD£1,130GBP
€2642EUR$2,750USD£2,259GBP
- Report
- April 2023
- 110 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- January 2022
- 200 Pages
Global
From €7206EUR$7,500USD£6,161GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,245GBP
- Report
- August 2022
Global
From €759EUR$790USD£649GBP
- Clinical Trials
- July 2021
- 157 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Clinical Trials
- February 2021
- 150 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Drug Pipelines
- August 2020
- 130 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Report
- October 2023
- 96 Pages
Global
From €3500EUR$3,902USD£3,097GBP
- Drug Pipelines
- June 2021
- 127 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Report
- March 2023
- 147 Pages
Global
From €5764EUR$5,999USD£4,928GBP
The Gonorrhea Drug market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat a variety of bacterial, viral, and fungal infections. Gonorrhea is a sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. Treatment for gonorrhea typically involves antibiotics, such as cephalosporins, macrolides, and fluoroquinolones. These drugs are used to reduce the symptoms of the infection and prevent further spread.
The market for Gonorrhea Drugs is highly competitive, with a number of major pharmaceutical companies offering products. These companies include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Bayer. Additionally, there are a number of smaller companies that specialize in the development and manufacture of Gonorrhea Drugs. Show Less Read more
